Ken Griffin Cytosorbents Corp Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.7 - $1.01 $350 - $505
500 New
500 $0
Q3 2023

Nov 14, 2023
BUY
$1.86 - $4.03 $558 - $1,209
300 Added 16.67%
2,100 $3,000
Q2 2023

Aug 14, 2023
SELL
$2.37 - $3.65 $17,775 - $27,375
-7,500 Reduced 80.65%
1,800 $6,000
Q1 2023

May 15, 2023
BUY
$1.79 - $4.17 $16,647 - $38,781
9,300 New
9,300 $31,000

Others Institutions Holding CTSO

# of Institutions
57
Shares Held
16.7M
Call Options Held
15.4K
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $41M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email